Nucleic acids encoding neutralizing GDF8 epitope-based peptides and fusion proteins
US7585648B2 · kind B2 · utility
4Cited by
20References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2008 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Apr 2, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides new, specific nucleic acids encoding antigenic peptides from the protein GDF8. The invention also provides nucleic acids encoding fusion proteins comprising the new peptides, immunogens and vaccines based on the nucleic acids encoding new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.